- Home
- ARWR vs CTRE Comparison
ARWR vs CTRE Comparison
Compare ARWR & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | CTRE |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 8.2B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | CTRE |
|---|---|---|
| Price | $63.20 | $38.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $77.55 | $40.89 |
| AVG Volume (30 Days) | ★ 3.1M | 1.8M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | N/A | ★ 90.43 |
| EPS | ★ 1.48 | 1.34 |
| Revenue | ★ $1,090,981,000.00 | $428,478,000.00 |
| Revenue This Year | N/A | $30.25 |
| Revenue Next Year | N/A | $27.26 |
| P/E Ratio | $43.74 | ★ $28.89 |
| Revenue Growth | ★ 43539.24 | 59.24 |
| 52 Week Low | $9.57 | $24.79 |
| 52 Week High | $76.76 | $39.27 |
Technical Indicators
Market Signals| Indicator | ARWR | CTRE |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 60.83 |
| Support Level | $66.91 | $35.60 |
| Resistance Level | $76.11 | $39.18 |
| Average True Range (ATR) | 4.11 | 0.93 |
| MACD | -0.77 | 0.18 |
| Stochastic Oscillator | 12.48 | 81.01 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.